Brief: enGene Reports Second Quarter 2025 Financial Results And Provides Business Update
12/06/2025 13:25
June 12 (Reuters) - enGene Holdings Inc ENGN.O: ENGENE REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE ENGENE HOLDINGS INC - Q2 LOSS PER SHARE $0.51 ENGENE HOLDINGS INC SAYS CASH AND MARKETABLE SECURITIES OF $251.5 MILLION EXPECTED TO PROVIDE RUNWAY INTO 2027 Source text: ID:nBwbj42nsa Further company coverage: ENGN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on enGene Therapeutics
See all newsBrief: Engene Reports Second Quarter 2026 Financial Results And Provides Business Update
enGene Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Engene Holdings Inc - To Change Name To Engene Therapeutics Inc. Effective April 8, 2026
Brief: Engene Holdings Enters Sales Agreement With Leerink Partners To Sell Common Shares
Brief: enGene Reports First Quarter 2026 Financial Results and Provides Business Update